Exercise in the Management of MAFLD
This online activity will showcase the key recommendations and clinical implications reported in the recently published ESSA Position Statement on Metabolic-Associated Fatty Liver Disease and will examine the key considerations for implementation of the guidelines.
Exercise in the Management of Metabolic-Associated Fatty Liver Disease (MAFLD) in Adults
A Position Statement from Exercise and Sport Science Australia
Metabolic-associated fatty liver disease (MAFLD, formerly known as non-alcoholic fatty liver disease/NAFLD) affects up to one third of Australians (recent estimate are as high as 39%!) and is becoming more prevalent with the global escalation of obesity-related chronic disease. In addition to increasing risk of end-stage liver disease and liver cancer, MAFLD plays a central role in the development and worsening of type 2 diabetes, cardiovascular disease and extrahepatic cancers. Given the lack of approved pharmaceutical agents, lifestyle therapy is the cornerstone of management for all people with MAFLD. It is now established that exercise is an effective therapy for reducing liver fat, even in the absence of weight loss.
Exercise professionals play a central role in the multidisciplinary integrated approach to MAFLD management. This online activity will showcase the key recommendations and clinical implications reported in the recently published ESSA Position Statement. In addition to highlighting principals of prescription (and the underlying evidence), the PD will examine the key considerations for implementation of the guidelines.
Prescriptive targets, outcome testing and evaluation, and special considerations will be discussed for practitioners working in clinical practice. Additionally, insights from people living with MAFLD will be explored giving a unique insight into challenges and opportunities for exercise care in people with MAFLD.
This is a recording of an ESSA webinar presented on 8 March 2024.
Presented by Dr Shelley Keating, AES, AEP
Dr Shelley Keating is an Accredited Exercise Physiologist and Senior Lecturer in Clinical Exercise Physiology at the School of Human Movement and Nutrition Sciences, The University of Queensland. Shelley leads a program of research centred on developing, delivering, and disseminating exercise interventions to manage cardiometabolic risk in adults with metabolic-associated fatty liver disease (MAFLD) and other obesity-related conditions. Her contribution to the field was recognised by the prestigious 2020 Australia and New Zealand Obesity Society Young Investigator award. Shelley has been an ESSA member since 2007 and has 16 years of clinical AEP experience in people with cardiometabolic disease including MAFLD.
Rates per person
| ESSA Member |
|
$33.00 |
| Non-Member |
|
$55.00 |
| ESSA Student Member |
|
$16.50 |
| Student Non-Member |
|
$27.50 |
| ESSA Member PD+ |
|
Complimentary |
| Non-Member PD+ |
|
Complimentary |
Please see terms & conditions for registration type definitions.
Access to Online Activity
Your online activity will be available in your ESSA learning profile after purchase. Please click here to access your ESSA learning profile.
Target Audience
Any Accredited Exercise Physiologist
ESSA CPD Points
Successful completion of an assessment, within 60 days is required to earn applicable CPD Points
Registration
Online: After signing into your ESSA profile, select the blue "Register Myself" button below
Manual Form: click here
International Membership Registration (including BASES, CEPA and SESNZ): click here.
Please note:
* Credit card payment is required with online registration.
* If a tax invoice is required for payment to be made, please use the manual form.
* Upon registering to any ESSA professional development, you automatically agree to our terms & conditions.
Disclaimers
All accredited persons, regardless of any professional development completed/ attended must refer to their accreditation’s Scope of Practice/Standards, and only treat/practice within the same.
ESSA confirms that at the date of release, this professional development meets the requirements of the ESSA Continuing Professional Development Points Guidelines. The information contained in this professional development is of a general nature only, and while every effort and care has been taken to ensure that all representations are accurate as at the date of its release, ESSA accepts no legal liability for any loss or damage suffered as a result of any information provided in this professional development.
ESSA recommends that its members seek appropriate independent professional advice specific to their particular purposes and circumstances (including the provision of medical advice to patients) before relying on it.
All professional development listed is correct at time of publication, and is subject to change at any time without notice.